MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
Linked In
WhatsApp

Home
Todays Market
Indian Stock Market Updates June 18, 2019

ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.2%
Tue, 18 Jun 12:24 PM

ASTRAZENECA PHARMA share price has zoomed 5% and is presently trading at Rs 1,921.

Meanwhile, the BSE HEALTHCARE Index is at 12,806 (up 0.2%).

Among the top Gainers in the BSE HEALTHCARE Index today is ASTRAZENECA PHARMA (up 5.1%).

STRIDES PHARMA SCIENCE and NARAYANA HRUDAYALAYA LTD are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,415 to Rs 1,921, registering a gain of Rs 506 (up 35.5%).

On the other hand, the BSE HEALTHCARE has moved down from 14,312 to 12,806, loss of 1,506 points (down 10.8%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 62.1%), DIVIS LABORATORIES (up 40.6%) and IPCA LABS (up 36.0%).

REVEALED: The Secret to potentially Making Rs 18,870, Rs 9,425 and Rs 7,315 in a Single Day...

What About the Benchmark Indices?

The BSE Sensex is at 39,146 (up 0.3%).

The top gainers among the BSE Sensex stocks today are INDUSIND BANK (up 2.7%), VEDANTA LTD (up 2.6%) and ICICI BANK (up 2.3%). Other gainers include POWER GRID (up 1.8%) and COAL INDIA (up 1.4%). The most traded stocks in the BSE Sensex are SBI and TATA MOTORS.

In the meantime, NSE Nifty is at 11,720 (up 0.4%). ZEE ENTERTAINMENT (up 2.9%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,548 to 39,146, registering a gain of 3,598 points (up 10.0%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 98 million for the quarter ended March 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 11.6% to Rs 1.9 billion during the period as against Rs 2.2 billion in January-March 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 88.1x.

Stock Market Updates

5 Reasons Why Sensex Surged 1,147 Points Today (Today's Market)

Mar 3, 2021 Closing

Indian share markets continued their momentum and ended their day on a strong note today.

J&K BANK Share Price Up by 8%; BSE BANKEX Index Up 2.8% (Today's Market)

Mar 3, 2021 03:35 PM

J&K BANK share price is trading up by 8% and its current market price is Rs 32. The BSE BANKEX is up by 2.8%. The top gainers in the BSE BANKEX Index are J&K BANK (up 7.6%) and RBL BANK (up 5.2%).

RELIANCE IND. Share Price Up by 5%; BSE OIL & GAS Index Up 1.3% (Today's Market)

Mar 3, 2021 03:27 PM

RELIANCE IND. share price is trading up by 5% and its current market price is Rs 2,216. The BSE OIL & GAS is up by 1.3%. The top gainers in the BSE OIL & GAS Index is RELIANCE IND. (up 5.1%). The top losers are PETRONET LNG (down 0.1%) and BPCL (down 0.4%).

AU SMALL FINANCE BANK at All Time High; BSE BANKEX Index Up 2.8% (Today's Market)

Mar 3, 2021 03:23 PM

AU SMALL FINANCE BANK share price has hit an all time high at Rs 1,224 (up 4.2%). The BSE BANKEX Index is up by 2.8%. Among the top gainers in the BSE BANKEX Index today are AU SMALL FINANCE BANK (up 4.2%) and KOTAK MAHINDRA BANK (up 3.0%).

REDINGTON Share Price Down by 5%; BSE 500 Index Up 1.9% (Today's Market)

Mar 3, 2021 03:13 PM

REDINGTON share price is trading down by 5% and its current market price is Rs 200. The BSE 500 is up by 1.9%. The top gainers in the BSE 500 Index are IFCI (up 19.9%) and IDBI BANK (up 12.1%). The top losers are REDINGTON (down 5.1%) and SYMPHONY (down 5.1%).

RBL BANK Share Price Up by 5%; BSE BANKEX Index Up 2.7% (Today's Market)

Mar 3, 2021 03:09 PM

RBL BANK share price is trading up by 5% and its current market price is Rs 249. The BSE BANKEX is up by 2.7%. The top gainers in the BSE BANKEX Index are RBL BANK (up 5.0%) and FEDERAL BANK (up 5.7%).

View More Indian Share Market News

S&P BSE SENSEX

51,444.65 2.28%
Mar 3, 2021 (Close)

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

FOLLOW

APP

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

MEMBER'S LOGINX

ASTRAZENECA PHARMA Surges by 5%; BSE HEALTHCARE Index Up 0.2% Tue, 18 Jun 12:24 PM

What About the Benchmark Indices?

ASTRAZENECA PHARMA Financial Update...

Indian Share Market Update: Top Gainers and Losers